Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The study is designed as an open labeled pilot trial to analyze the acute responses of
glucose, GLP-1, GIP, insulin secretory,and glucagon to a mixed meal tolerance test (MMTT) or
intravenous glucose tolerance tests (IVGTT) with and without pretreatment with Exenatide
(Byetta) 5 mcg sc.
The investigators will also test the effects of Exenatide on gastric emptying during the
MMTT.